Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 290
Selected: 0
NCT IDTitle
NCT03606070Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study
NCT04823403Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular Carcinoma
NCT05890781Engineering Immune Organoids to Study Pediatric Cancer
NCT03609112Neurocognitive Risks in Children With Solid Tumors
NCT06439888Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer
NCT04965766Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer
NCT03983369Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults
NCT01159288Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes
NCT04794296Recommendations for the Treatment of Children With Acute Lymphoblastic Leukemia in the GFAOP
NCT02613962Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular Profiling
NCT05947903Validation of the European Oncology Quality of Life Toolkit
NCT03356535Metabolic Signature of Healthy Lifestyle and HCC
NCT07483983Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance
NCT02515877Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers
NCT01857453Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas
NCT00162708Very Intense Radiotherapy-Chemotherapy Regimen in Advanced HNSCC
NCT03324958VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.
NCT07303387Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors.
NCT00127088Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients
NCT02516774A Trial of Adalimumab Combined to Chemotherapy and Radiotherapy in Patients With Anaplastic Thyroid Cancers
NCT02679963Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer
NCT02105168Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment
NCT01864772Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC
NCT01504815Adaptive Radiation Treatment for Head and Neck Cancer
NCT06508216A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
NCT06828263Prospective Evaluation of Imaging Response Biomarkers During [177Lu]Lu-PSMA in Metastatic Castration-resistant Prostate Cancer
NCT01557114Study of Radiotherapy Administered in Combination With Ipilimumab in Patients With Unresectable Stage III or Stage IV Advanced Malignant Melanoma
NCT05830084Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
NCT02997384Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
NCT05977062Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia
NCT06160596Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
NCT05119010A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
NCT01701479Long Term Continuous Infusion ch14.18/CHO Plus s.c. Aldesleukin (IL-2)
NCT02131480Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma
NCT00162669Bevacizumab in Advanced Hepatocellular Carcinoma
NCT00346645A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer
NCT03596281Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer
NCT03246841Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
NCT01887522Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults
NCT00367861Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance
NCT01112254Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer
NCT05071001Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence
NCT02992912Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours
NCT07016230Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)
NCT06078384Pembrolizumab and Chemotherapy Treatment or no Treatment Guided by the Level of TILs in Resected Early-stage TNBC
NCT00162721The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas
NCT00552149Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin
NCT07512882Cohort of Patients With Chronic Myelomonocytic Leukemia
NCT01516580Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
NCT02488369Diagnostic Qualities of the Positron Emission Tomography Coupled to the Scanner (PET / CT) in the Assessment of Response to Non-Hodgkin's Lymphoma Therapy in Children and Adolescents